IL311480A - Reticuloclavin-3 variants and treatment of asthma with interleukin-4 alpha receptor antagonists - Google Patents
Reticuloclavin-3 variants and treatment of asthma with interleukin-4 alpha receptor antagonistsInfo
- Publication number
- IL311480A IL311480A IL311480A IL31148024A IL311480A IL 311480 A IL311480 A IL 311480A IL 311480 A IL311480 A IL 311480A IL 31148024 A IL31148024 A IL 31148024A IL 311480 A IL311480 A IL 311480A
- Authority
- IL
- Israel
- Prior art keywords
- rcn3
- reticulocalbin
- il4r
- interleukin
- asthma
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163250546P | 2021-09-30 | 2021-09-30 | |
| PCT/US2022/077088 WO2023056254A1 (en) | 2021-09-30 | 2022-09-27 | Reticulocalbin-3 (rcn3) variants and treatment of asthma with interleukin-4 receptor alpha (il4r) antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL311480A true IL311480A (en) | 2024-05-01 |
Family
ID=83902767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL311480A IL311480A (en) | 2021-09-30 | 2022-09-27 | Reticuloclavin-3 variants and treatment of asthma with interleukin-4 alpha receptor antagonists |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230151426A1 (https=) |
| EP (1) | EP4409037A1 (https=) |
| JP (1) | JP2024536001A (https=) |
| KR (1) | KR20240067064A (https=) |
| CN (1) | CN117957332A (https=) |
| CA (1) | CA3230302A1 (https=) |
| IL (1) | IL311480A (https=) |
| MX (1) | MX2024003921A (https=) |
| WO (1) | WO2023056254A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| WO2011156000A2 (en) * | 2010-06-07 | 2011-12-15 | Aerovance, Inc. | Use of il-4/il-13 antagonists to treat eosinophilic disorders |
| AR098155A1 (es) * | 2013-10-23 | 2016-05-04 | Genentech Inc | Métodos para diagnosticar y tratar trastornos eosinofílicos |
-
2022
- 2022-09-27 KR KR1020247007006A patent/KR20240067064A/ko active Pending
- 2022-09-27 US US17/935,785 patent/US20230151426A1/en active Pending
- 2022-09-27 JP JP2024513821A patent/JP2024536001A/ja active Pending
- 2022-09-27 EP EP22793348.8A patent/EP4409037A1/en active Pending
- 2022-09-27 CA CA3230302A patent/CA3230302A1/en active Pending
- 2022-09-27 IL IL311480A patent/IL311480A/en unknown
- 2022-09-27 MX MX2024003921A patent/MX2024003921A/es unknown
- 2022-09-27 CN CN202280059731.6A patent/CN117957332A/zh active Pending
- 2022-09-27 WO PCT/US2022/077088 patent/WO2023056254A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN117957332A (zh) | 2024-04-30 |
| EP4409037A1 (en) | 2024-08-07 |
| KR20240067064A (ko) | 2024-05-16 |
| CA3230302A1 (en) | 2023-04-06 |
| JP2024536001A (ja) | 2024-10-04 |
| MX2024003921A (es) | 2024-04-22 |
| WO2023056254A1 (en) | 2023-04-06 |
| AU2022356375A1 (en) | 2024-03-14 |
| US20230151426A1 (en) | 2023-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL314442A (en) | Trinucleotide cap analogs and methods of using them | |
| ZA202107515B (en) | Liquid composition comprising antibody of human interleukin-4 receptor alpha | |
| GB2617483B (en) | Interleukin-18 variants and methods of use | |
| JO2865B1 (en) | Antibodies of high affinity for human interleukin-4 receptors | |
| IL319779A (en) | New bicyclic heterocyclic compounds and their uses | |
| AU2003273300A8 (en) | Modified glp-1 receptor agonists and their pharmacological methods of use | |
| IL314922A (en) | Targeted cytokines and methods of using them | |
| IL284670A (en) | A mixture of peptide ingredients for skin regeneration and healing and its use | |
| EP4334706A4 (en) | MULTIOMICS ANALYSIS DEVICE AND METHODS OF USE THEREOF | |
| IL285730A (en) | Compounds with proptosis-inducing activity and methods of using them | |
| GB2615237B (en) | Face shield with powered air purifying respirator and methods of use | |
| SG11202109590VA (en) | T cell receptors and methods of use thereof | |
| IL311480A (en) | Reticuloclavin-3 variants and treatment of asthma with interleukin-4 alpha receptor antagonists | |
| GB2613900B (en) | Novel compounds and methods of use thereof | |
| HK40114684A (en) | Reticulocalbin-3 (rcn3) variants and treatment of asthma with interleukin-4 receptor alpha (il4r) antagonists | |
| GB0611154D0 (en) | Novel receptor antagonists and their methods of use | |
| IL299104A (en) | Intracellular administration of a CEBP antagonist and methods of use | |
| EP4110322A4 (en) | SELECTIVE COVALENT ANDROGEN RECEPTOR ANTAGONISTS (SARCAS) AND METHODS OF USE THEREOF | |
| IL313573A (en) | Transgenic sirpα variants and methods of using them | |
| IL290221A (en) | T-cell receptors and methods for their use | |
| IL311999A (en) | New modulators of EHMT1 and EHMT2 and their therapeutic use | |
| IL299654A (en) | BRK peptides and methods of use | |
| EP4259181A4 (en) | INTERLEUKIN-17B RECEPTOR (IL-17RB) ANTAGONIST AND ITS USE | |
| IL318954A (en) | Recombinant interleukin-2-related receptors and methods of use | |
| IL321736A (en) | Engineered TGFβRII Variants and Methods for Using Them |